Surgery Medical News about Cholangiocarcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
World Journal of Gastroenterology, 09/23/09

Aljiffry M et al. – Several advances in diagnosis, treatment and palliation of cholangiocarcinoma (CC) have occurred in the last decades. CC is a relatively rare tumor and the main risk factors are: chronic inflammation, genetic predisposition and congenital abnormalities of the biliary tree. While the incidence of intra–hepatic CC is increasing, the incidence of extra–hepatic CC is trending down. The only curative treatment for CC is surgical resection with negative margins. Liver transplantation has been proposed only for selected patients with hilar CC that cannot be resected who have no metastatic disease after a period of neoadjuvant chemo–radiation therapy.

<< Previous
Use of Wound-Protection System and Postoperative Wound-Infection...

Next >>
Is Thoracoscopic Pneumonectomy Safe